Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 03-2025 | 01-2025 | 12-2024 | 10-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,836 | -131,218 | N/A | -82,710 | -122,529 |
| Depreciation Amortization | 205 | 691 | N/A | 461 | 678 |
| Accounts payable and accrued liabilities | -3,119 | -3,579 | N/A | -4,358 | 1,011 |
| Other Working Capital | 1,410 | 3,496 | N/A | -2,097 | 12,590 |
| Other Operating Activity | 5,773 | 18,067 | 0 | 8,842 | 16,598 |
| Operating Cash Flow | $-47,567 | $-112,543 | $N/A | $-79,862 | $-91,652 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -525 | -414 | N/A | -287 | -346 |
| Purchase Of Investment | -23,493 | -7,547 | N/A | -984 | -148,437 |
| Sale Of Investment | 20,300 | 102,313 | N/A | 87,106 | 93,079 |
| Investing Cash Flow | $-3,718 | $94,352 | $N/A | $85,835 | $-55,704 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,223 | 59,838 | N/A | 3,295 | 153,606 |
| Other Financing Activity | 0 | 95,230 | 0 | 0 | 0 |
| Financing Cash Flow | $2,223 | $155,068 | $N/A | $3,295 | $153,606 |
| Exchange Rate Effect | 2,240 | -725 | N/A | 524 | 571 |
| Beginning Cash Position | 182,978 | 31,789 | N/A | 31,789 | 33,778 |
| End Cash Position | 136,156 | 167,941 | N/A | 41,581 | 40,599 |
| Net Cash Flow | $-46,822 | $136,152 | $N/A | $9,792 | $6,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,567 | -112,543 | N/A | -79,862 | -91,652 |
| Capital Expenditure | -525 | -414 | N/A | -287 | -346 |
| Free Cash Flow | -48,092 | -112,957 | 0 | -80,149 | -91,998 |